Could Rapamycin Be Our Next Weapon In The Fight For Longevity?
Rapamycin, also known as sirolimus, is an immunosuppressant drug that was approved by the Food and Drug Administration (FDA) in 1999.
Stay updated with breaking news from Cell Cycle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rapamycin, also known as sirolimus, is an immunosuppressant drug that was approved by the Food and Drug Administration (FDA) in 1999.
Researchers have deciphered a signaling cascade through which inborn errors in metabolism provoke deadly neuroendocrine tumors in the adrenal glands.
The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.
Scientists from China have recently deciphered the genetic network and biological mechanisms associated with COVID-19 myocarditis using bioinformatic methods.
In a recent study under review at the Scientific Reports journal and currently posted to the Research Square* preprint server, researchers synthesized and evaluated the antitumoral (against several cancer cell lines) and antiviral [against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] properties of 3-spiro-indolin-2-ones.